SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122804
Filing Date
2024-11-07
Accepted
2024-11-07 07:30:26
Documents
85
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20240930.htm   iXBRL 10-Q 2432217
2 EX-31.1 aplt-ex31_1.htm EX-31.1 10771
3 EX-31.2 aplt-ex31_2.htm EX-31.2 14275
4 EX-32.1 aplt-ex32_1.htm EX-32.1 6083
5 EX-32.2 aplt-ex32_2.htm EX-32.2 6314
  Complete submission text file 0000950170-24-122804.txt   9410296

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aplt-20240930.xsd EX-101.SCH 1398687
87 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20240930_htm.xml XML 1472520
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 241433184
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)